Predictors of compliance with antihypertensive therapy in a high-risk medicaid population (Q46806767)

25 December 2017

title

Predictors of compliance with antihypertensive therapy in a high-risk medicaid population (English)

1 reference

25 December 2017

author name string

Fadia T Shaya

1 reference

25 December 2017

Dongyi Du

1 reference

25 December 2017

Confidence M Gbarayor

1 reference

25 December 2017

Feride Frech-Tamas

1 reference

25 December 2017

Helen Lau

1 reference

25 December 2017

Matthew R Weir

1 reference

25 December 2017

publication date

1 January 2009

1 reference

25 December 2017

Journal of the National Medical Association

published in

1 reference

25 December 2017

volume

101

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

34-39

1 reference

25 December 2017

The burden of adult hypertension in the United States 1999 to 2000: a rising tide

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Selected major risk factors and global and regional burden of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

The costs of interrupting antihypertensive drug therapy in a Medicaid population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Antihypertensive prescribing: do we have reason to celebrate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

The Effects of Initial Drug Choice and Comorbidity on Antihypertensive Therapy Compliance Results From a Population-Based Study in the Elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Medication adherence and persistence as the cornerstone of effective antihypertensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Paradoxical relations of drug treatment with mortality in older persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Examination of treatment pattern differences by race

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Racial differences in blood pressure control: potential explanatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Physicians' characteristics influence patients' adherence to medical treatment: Results from the Medical Outcomes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Clinicians and patients with hypertension: Unsettled issues about compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Compliance with pharmacological therapy in hypertension: can we do better, and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

Pharmacoeconomic burden of undertreating hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930808-7

10.1016/S0027-9684(15)30808-7

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

release_mj5pnz4qfrhzlicparcttolyyu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mj5pnz4qfrhzlicparcttolyyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017